# Vitalant – FDA Inspection, Jan 9, 2018

Source: https://www.keypedia.com/records/fda_inspections/vitalant/5fb2f844-d192-4c57-902a-2a664dbf8035
Source feed: FDA_Inspections

> FDA inspection 1037093 of Vitalant, January 09, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 606 and 630. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1037093
- Company Name: Vitalant
- Inspection Date: 2018-01-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1319318 - 2026-05-18
- FDA Inspection 1153285 - 2021-09-08
- FDA Inspection 951861 - 2015-12-10
- FDA Inspection 886438 - 2014-06-19
- FDA Inspection 774848 - 2012-03-28

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)

Company: https://www.keypedia.com/companies/vitalant/5c938a80-0a89-485c-ac2e-0430061ab038

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
